GE HealthCare Technologies (NASDAQ:GEHC) Stock Rating Lowered by Wall Street Zen

GE HealthCare Technologies (NASDAQ:GEHC) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

A number of other equities analysts have also issued reports on GEHC. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Citigroup cut their price objective on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a report on Wednesday, March 11th. Barclays raised their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Friday, February 6th. Finally, Bank of America upped their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Stock Down 1.1%

NASDAQ:GEHC opened at $69.61 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $89.77. The company has a market cap of $31.76 billion, a PE ratio of 15.26, a P/E/G ratio of 1.53 and a beta of 1.03. The company’s 50 day moving average is $79.22 and its two-hundred day moving average is $78.47.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter last year, the company posted $1.45 earnings per share. The business’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

Hedge Funds Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently modified their holdings of the stock. Western Wealth Management LLC grew its holdings in GE HealthCare Technologies by 2.4% during the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after acquiring an additional 125 shares during the period. United Community Bank lifted its holdings in GE HealthCare Technologies by 10.2% in the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after acquiring an additional 130 shares during the period. Parkside Financial Bank & Trust boosted its position in GE HealthCare Technologies by 3.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after purchasing an additional 134 shares in the last quarter. Thoma Capital Management LLC boosted its position in GE HealthCare Technologies by 1.4% in the 4th quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares in the last quarter. Finally, True North Advisors LLC grew its stake in shares of GE HealthCare Technologies by 2.0% during the 3rd quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.